Including non-concurrent control patients in the analysis of platform trials: is it worth it?

Background Platform trials allow adding new experimental treatments to an on-going trial. This feature is attractive to practitioners due to improved efficiency. Nevertheless, the operating characteristics of a trial that adds arms have not been well-studied. One controversy is whether just the conc...

Ausführliche Beschreibung